Urological Surgical Robots: Top 5 Options in the UK for 2026

Published on Monday, 26 January 2026

Urological surgical robots are advanced, computer-assisted platforms designed to support surgeons in procedures such as prostatectomy, partial nephrectomy and reconstructive urology. In the UK market these systems appeal to patients and hospitals because they can increase surgical precision, enable minimally invasive approaches, reduce blood loss and shorten hospital stays. Clinicians and commissioners also value better ergonomics for surgeons, integrated imaging and data capture for audit and training, and growing evidence that robotic techniques can improve functional recovery in selected procedures. This page currently lists no ranked 'top' options for 2026 due to variation in device commissioning, local NHS and private hospital adoption, and the evolving regulatory and purchasing landscape. Instead of a ranked shortlist, the content here explains the category, typical benefits and trade offs, and how UK hospitals and patients commonly choose a platform.

Top Picks Summary

  1. da Vinci Xi Surgical System
  2. da Vinci SP Surgical System
  3. Medtronic Hugo RAS System
  4. CMR Versius Surgical System
  5. Hinotori Surgical Robot System
1
MARKET LEADER MULTI-QUADRANT

da Vinci Xi Surgical System

da Vinci Xi Surgical System

The da Vinci Xi is the established market leader in urological surgical robots, prized for its mature instrument ecosystem, advanced wristed instruments and high-fidelity 3D imaging that together deliver consistent outcomes in complex urologic procedures such as radical prostatectomy. Its large installed base and extensive training and service network create financial advantages through predictable maintenance pathways and high procedure volumes, though it carries a higher upfront cost and larger footprint compared with newer modular or single-port entrants. Against competitors like the da Vinci SP, Hugo RAS and Versius, the Xi remains the dependable multi-port workhorse preferred by many high-volume urology centers for versatility and broad instrument availability.

4.6
Da Vinci Xi Surgical System - ROBOTICS

Review Summary

92%

"Long-established platform praised for reliability, broad instrument set, and clinical versatility; purchasers report strong institutional support and high case throughput but note very high acquisition and maintenance costs."

2
SINGLE-PORT UROLOGY SPECIALIST

da Vinci SP Surgical System

da Vinci SP Surgical System

The da Vinci SP is Intuitive's single-port platform optimized for minimally invasive urological procedures, offering a true single-incision approach with articulating multi-channel instruments that reduce external scarring and can simplify patient recovery. Technically, it provides targeted access in confined pelvic spaces where single-site ergonomics matter, although its instrument breadth and case throughput can be narrower than multi-port systems, and disposables can increase per-case costs. Compared with modular rivals like Hugo RAS and Versius, SP's unique single-site capability makes it the leading choice where incision minimization and cosmesis are clinical priorities.

4.4

Review Summary

88%

"Single-port system valued for reduced scarring and excellent single‑site access in urologic procedures, with users noting a steeper learning curve and a more limited instrument range compared with multiport platforms."

3
MODULAR COST-EFFECTIVE RAS

Medtronic Hugo RAS System

Medtronic Hugo RAS System

The Hugo RAS System positions itself as a modern, modular challenger in urological robotics with independent arm carts and an open-console design that enable flexible OR configuration and potential cost savings through scalable deployment. Its design emphasizes interoperability with hospital systems and competitive pricing that can lower total cost of ownership for health systems looking to diversify suppliers, though it has a smaller installed base than the da Vinci family and is still building procedure-specific ecosystems. Compared to the established Xi/SP and compact Versius, Hugo's chief advantages are modularity and procurement flexibility that can translate into financial and logistical benefits for agile surgical programs.

4.2

Review Summary

85%

"Modular, open-platform design is praised for operating room flexibility and potential cost advantages; early adopters report some software/hardware refinements needed and a smaller installed base than the market leader."

4
PORTABLE BEDSIDE VERSATILITY

CMR Versius Surgical System

CMR Versius Surgical System

Versius from CMR Surgical is a lightweight, modular robotic system aimed at reducing capital and running costs for urological surgery by using compact bedside arms and an open surgeon console to improve OR ergonomics and turnover. Financially positioned as cost-competitive, Versius appeals to hospitals seeking lower entry costs and easier scaling versus larger multi-arm platforms, while delivering technical accuracy for common urological procedures; it does not, however, offer single-port capability like the da Vinci SP. In comparison to the Xi and Hugo, Versius trades the broad instrument catalogue of legacy systems for affordability, mobility and modern ergonomics targeted at expanding robotic access.

4.3

Review Summary

86%

"Compact, arm-based system is frequently commended for portability and surgeon ergonomics, while users sometimes mention a less mature instrument portfolio and ecosystem compared with incumbent systems."

5
JAPANESE PRECISION UROLOGY

Hinotori Surgical Robot System

Hinotori Surgical Robot System

Hinotori, developed by Medicaroid, is a Japanese robotic platform tailored to precision and ergonomics in urological surgery, offering compact architecture and locally optimized support that can reduce lifecycle costs in domestic and regional markets. Technically competitive for pelvic procedures, Hinotori is marketed as a cost-sensitive alternative with strong service responsiveness in Japan, though it has a smaller international footprint compared with Intuitive and is still expanding its global instrument and training ecosystem. For urology centers prioritizing regional support and competitive pricing while gaining modern robotic capabilities, Hinotori represents a compelling choice.

4.1

Review Summary

84%

"High-precision system with good ergonomics and strong regional support, delivering reliable urologic performance for users, though global availability and long-term comparative evidence remain limited."

How to Choose

What the Research Says About Robotic Urological Surgery

Clinical studies and systematic reviews over the last two decades show consistent benefits of robot-assisted urological surgery for certain outcomes, while highlighting mixed results for cost and long-term oncological outcomes. For many common urological procedures, evidence suggests reduced blood loss, shorter length of stay and faster early recovery compared with open surgery. Randomized trials and meta-analyses comparing minimally invasive approaches with open surgery or conventional laparoscopy show improvements in perioperative outcomes, but the magnitude of benefit depends on the procedure, surgeon experience and institutional pathways. Health technology assessments in the UK emphasise the importance of training, case volume and local commissioning when evaluating cost-effectiveness.

Meta-analyses report lower intraoperative blood loss and shorter hospital stay for robot-assisted radical prostatectomy versus open surgery.

Evidence for functional outcomes such as urinary continence and sexual function often favours minimally invasive approaches in the early postoperative period, with longer term differences less clear.

Comparisons versus conventional laparoscopy show variable advantages that depend on surgeon experience and procedure complexity.

Cost-effectiveness depends on case volume, purchase and maintenance costs, and potential downstream savings from shorter stays and fewer complications; UK assessments typically require local evaluation before widespread adoption.

Training, credentialing and supervised learning curves are critical; outcomes are consistently better in centres with formal robotic programmes and higher case volumes.

Frequently Asked Questions

Which urological robot should I choose for prostatectomy?

Choose the da Vinci Xi Surgical System for complex urological procedures like radical prostatectomy because it has four articulated bedside arms with high-definition 3D vision and a broad library of wristed instruments; it’s rated 4.6.

What capability does the da Vinci SP offer for urology?

The da Vinci SP Surgical System offers true single-port access for reduced-incision urological surgery, using a dedicated single-port 3D endoscope plus multi-jointed articulating multi-channel instruments for confined pelvic work; it’s rated 4.4.

Does Hugo RAS System cost less than da Vinci robots?

The provided data doesn’t list any prices, so I can’t compare costs; it only states the Medtronic Hugo RAS System uses independent arm carts and a modular setup intended to lower capital and OR footprint costs for urology programs; it’s rated 4.2.

How does Hugo RAS System fit existing OR workflows?

Medtronic Hugo RAS System is described as having an open-console design and an intended compatibility with existing workflows, using independent arm carts and a modular setup to enable flexible OR configuration; it’s rated 4.2.

Conclusion

In summary, urological surgical robots offer practical benefits for selected patients and procedures in the UK, but device choice and local adoption vary by hospital and commissioning decisions. We hope this overview helped you understand the category even though there are no ranked 'top' options listed for 2026. Use the site search to refine or broaden your query — for example by procedure type, hospital region, or manufacturer — to find the most relevant local information.

Don't see your product here?

If you're a brand owner wondering why your product isn't listed, we can help you understand our ranking criteria.

Learn why

As an Amazon Associate and affiliate partner, InceptionAi earns from qualifying purchases. This does not influence our rankings. Our product search and market analysis are separate from the selling part.